XML 27 R16.htm IDEA: XBRL DOCUMENT v3.23.2
Stock Appreciation Rights, Deferred Compensation and Redeemable Noncontrolling Interests
 3 Months Ended
Jul. 31, 2023
Stock Appreciation Rights, Deferred Compensation and Redeemable Noncontrolling Interests  
Stock Appreciation Rights, Deferred Compensation and Redeemable Noncontrolling Interests Stock Appreciation Rights, Deferred Compensation and Redeemable Noncontrolling Interests
The following table presents a summary of changes to the liabilities for stock appreciation rights, deferred compensation and redeemable noncontrolling interests:
Stock
Appreciation
Rights		Deferred
Compensation		Redeemable
Noncontrolling
Interests
(in thousands)
Balance as of April 30, 2023$32,432 $2,407 $12,002 
Amounts redeemed(1,727)(585)(2,931)
Change in fair value1,218 72 408 
Balance as of July 31, 2023$31,923 $1,894 $9,479 
Classified as current as of April 30, 2023$7,446 $545 $2,726 
Classified as long-term as of April 30, 202324,986 1,862 9,276 
Classified as current as of July 31, 2023$6,247 $— $— 
Classified as long-term as of July 31, 202325,676 1,894 9,479 
Total expense related to these instruments was $1.7 million and $2.8 million during the three months ended July 31, 2023 and 2022, respectively, and was included in selling, general and administrative expenses in the Condensed Consolidated Statements of Operations and Comprehensive Income. Current and long-term liabilities for stock appreciation rights, deferred compensation and redeemable noncontrolling interests are included in other accrued expenses and liabilities and other liabilities, respectively, in the Condensed Consolidated Balance Sheets. See Note 13, "Stock Appreciation Rights, Deferred Compensation and Redeemable Noncontrolling Interests," in the Company's Annual Report on Form 10-K for the year ended April 30, 2023 for more information regarding stock appreciation rights, deferred compensation and redeemable noncontrolling interests.